151 related articles for article (PubMed ID: 38275831)
1. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.
Ielasi L; Stefanini B; Conti F; Tonnini M; Tortora R; Magini G; Sacco R; Pressiani T; Trevisani F; Foschi FG; Piscaglia F; Granito A; Tovoli F
Curr Oncol; 2024 Jan; 31(1):547-557. PubMed ID: 38275831
[TBL] [Abstract][Full Text] [Related]
2. New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Kim JH; Shim JH; Lee HC; Sung KB; Ko HK; Ko GY; Gwon DI; Kim JW; Lim YS; Park SH
Liver Int; 2017 Dec; 37(12):1861-1868. PubMed ID: 28581250
[TBL] [Abstract][Full Text] [Related]
3. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
[TBL] [Abstract][Full Text] [Related]
5. Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers.
Kimura H; Ohkawa K; Miyazaki M; Sakakibara M; Imanaka K; Tamura T; Sueyoshi H; Takada R; Fukutake N; Uehara H; Ashida R; Ioka T; Nakazawa T; Nakanishi K; Katayama K
Hepatol Int; 2017 Jan; 11(1):105-114. PubMed ID: 27766479
[TBL] [Abstract][Full Text] [Related]
6. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
[TBL] [Abstract][Full Text] [Related]
7. Validation of Kinki Criteria, a Modified Substaging System, in Patients with Intermediate Stage Hepatocellular Carcinoma.
Arizumi T; Ueshima K; Iwanishi M; Minami T; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ida H; Sakurai T; Kitano M; Nishida N; Kudo M
Dig Dis; 2016; 34(6):671-678. PubMed ID: 27750236
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Arizumi T; Ueshima K; Iwanishi M; Minami T; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Ida H; Minami Y; Sakurai T; Kitano M; Nishida N; Kudo M
Oncology; 2015; 89 Suppl 2():47-52. PubMed ID: 26584036
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients.
Weinmann A; Koch S; Sprinzl M; Kloeckner R; Schulze-Bergkamen H; Düber C; Lang H; Otto G; Wörns MA; Galle PR
Liver Int; 2015 Feb; 35(2):591-600. PubMed ID: 25290314
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
Tian Y; Lyu H; He Y; Kanduri HK
J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
[TBL] [Abstract][Full Text] [Related]
11. Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria).
Kudo M; Arizumi T; Ueshima K; Sakurai T; Kitano M; Nishida N
Dig Dis; 2015 Oct; 33(6):751-8. PubMed ID: 26488473
[TBL] [Abstract][Full Text] [Related]
12. Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2.
Arizumi T; Minami T; Chishina H; Kono M; Takita M; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Kamata K; Minaga K; Komeda Y; Takenaka M; Sakurai T; Watanabe T; Nishida N; Kudo M
Dig Dis; 2017; 35(6):583-588. PubMed ID: 29040991
[TBL] [Abstract][Full Text] [Related]
13. Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification.
Yamamoto M; Kobayashi T; Hashimoto M; Kuroda S; Kawaoka T; Aikata H; Chayama K; Ohdan H
BMC Cancer; 2021 Jun; 21(1):668. PubMed ID: 34090354
[TBL] [Abstract][Full Text] [Related]
14. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.
Zhang N; Gu J; Yin L; Wu J; Du MY; Ding K; Huang T; He X
Oncotarget; 2016 Dec; 7(49):81389-81401. PubMed ID: 27835609
[TBL] [Abstract][Full Text] [Related]
16. Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B.
Yoo JJ; Yu SJ; Lee B; Cho EJ; Lee JH; Kim SG; Kim YJ; Kim YS; Yoon JH
Gut Liver; 2020 May; 14(3):377-386. PubMed ID: 31533399
[TBL] [Abstract][Full Text] [Related]
17. A new substage classification strategy for Barcelona Clinic Liver Cancer stage B patients with hepatocellular carcinoma.
Hu KS; Tang B; Yuan J; Lu SX; Li M; Chen RX; Zhang L; Ren ZG; Yin X
J Gastroenterol Hepatol; 2019 Nov; 34(11):1984-1991. PubMed ID: 30932246
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
19. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
